• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AC8 0.00% 4.0¢

AUSCANN GROUP HOLDINGS LTD - Announcements

AusCann Group Holdings Limited is an Australia-based company focused on the development... AusCann Group Holdings Limited is an Australia-based company focused on the development and commercialization of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. Its products include Neuvis, CPAT-01, DermaCann and MicroMax. CPAT-01 is a liquid, oral veterinary medicine containing standardized tetrahydrocannabinol (THC) and cannabinoids (CBD) whole plant extracts in a proprietary ratio to target pain and inflammation in dogs. DermaCann is a CBD-derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. The product is a liquid oral oil formulation containing CBD in a patented combination with other bioactive lipids designed to target inflammation and immune modulation pathways. MicroMAX is an encapsulation technology for use in the field of animal therapeutics. Its subsidiaries include AusCann Operations Pty Ltd and CannPal Animal Therapeutics Limited.More

Announcements


AC8 March 2024 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE30/04/24 download Created with Sketch. 148.8KB
AC8 Half Yearly Report and AccountsPRICE SENSITIVE03/04/24 download Created with Sketch. 353.37KB
AC8 Cancel - Proposed issue of securities - AC815/02/24 download Created with Sketch. 17.92KB
AC8 Supplementary ProspectusPRICE SENSITIVE15/02/24 download Created with Sketch. 29.43KB
AC8 Withdrawal of Share Purchase Plan15/02/24 download Created with Sketch. 79.64KB
AC8 Update to Share Purchase Plan Timetable05/02/24 download Created with Sketch. 108.37KB
AC8 December 2023 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE30/01/24 download Created with Sketch. 345.7KB
AC8 ProspectusPRICE SENSITIVE25/01/24 download Created with Sketch. 306.66KB
AC8 Proposed issue of securities - AC825/01/24 download Created with Sketch. 28.68KB
AC8 Share Purchase PlanPRICE SENSITIVE25/01/24 download Created with Sketch. 118.66KB
AC8 Additional Secured Loan to ECCPRICE SENSITIVE23/01/24 download Created with Sketch. 139.1KB
AC8 Change of Auditor03/01/24 download Created with Sketch. 68.5KB
AC8 Change of Company Address03/01/24 download Created with Sketch. 77.13KB
AC8 Change of Company Secretary02/01/24 download Created with Sketch. 102.32KB
AC8 Initial Director's Interest Notice - A. Chapman01/12/23 download Created with Sketch. 159.41KB
AC8 Final Director's Interest Notice - T. McGrouther01/12/23 download Created with Sketch. 137.57KB
AC8 Appointment of New Chairman01/12/23 download Created with Sketch. 82.9KB
AC8 Results of Annual General Meeting30/11/23 download Created with Sketch. 175.1KB
AC8 September 2023 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE31/10/23 download Created with Sketch. 1.08MB
AC8 Notice of Annual General Meeting/Proxy Form27/10/23 download Created with Sketch. 548.54KB
AC8 Letter to Shareholders - Notice of Annual General Meeting27/10/23 download Created with Sketch. 322.8KB
AC8 Appendix 4G and Corporate Governance Statement27/10/23 download Created with Sketch. 397.09KB
AC8 Annual Report27/10/23 download Created with Sketch. 1.36MB
AC8 Notification of cessation of securities - AC826/10/23 download Created with Sketch. 23.75KB
AC8 New Secured Loan Agreements Executed with ECCPRICE SENSITIVE25/10/23 download Created with Sketch. 186.47KB
AC8 Change of Address Notifications15/09/23 download Created with Sketch. 79.69KB
AC8 2023 Annual General Meeting - Key Dates15/09/23 download Created with Sketch. 81.97KB
AC8 Appendix 4E and 30 June 2023 Preliminary Financial ReportPRICE SENSITIVE31/08/23 download Created with Sketch. 495.86KB
AC8 June 2023 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE31/07/23 download Created with Sketch. 1.05MB
AC8 Expanded Collaboration with European Cannabis CorpPRICE SENSITIVE31/07/23 download Created with Sketch. 112.93KB
AC8 Final Director's Interest Notice - C. Mews29/06/23 download Created with Sketch. 141.42KB
AC8 Initial Director's Interest Notice - B. Mitchell29/06/23 download Created with Sketch. 135.31KB
AC8 Appointment of Independent Non-Executive Director29/06/23 download Created with Sketch. 84.36KB
AC8 Settlement of Wangara FacilityPRICE SENSITIVE13/06/23 download Created with Sketch. 82.92KB
AC8 March 2023 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE28/04/23 download Created with Sketch. 1.05MB
AC8 Wangara Facility SalePRICE SENSITIVE04/04/23 download Created with Sketch. 89.26KB
AC8 AusCann to Partially Divest Animal Health AssetsPRICE SENSITIVE10/03/23 download Created with Sketch. 241.08KB
AC8 Appendix 4D and Half-Year Financial Report 31 December 2022PRICE SENSITIVE28/02/23 download Created with Sketch. 477.45KB
AC8 December 2022 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE31/01/23 download Created with Sketch. 1.17MB
AC8 Final Director's Interest Notice03/01/23 download Created with Sketch. 134.69KB
AC8 Resignation of Non-Executive Director03/01/23 download Created with Sketch. 84.11KB
AC8 Results of Annual General Meeting30/11/22 download Created with Sketch. 266.86KB
AC8 Market Update for ShareholdersPRICE SENSITIVE30/11/22 download Created with Sketch. 819.88KB
AC8 September 2022 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE31/10/22 download Created with Sketch. 1.03MB
AC8 Notice of Annual General Meeting/Proxy Form28/10/22 download Created with Sketch. 398.82KB
AC8 Letter to Shareholders - Notice of Annual General Meeting28/10/22 download Created with Sketch. 342.19KB
AC8 Annual Report28/10/22 download Created with Sketch. 870.8KB
AC8 Annual Financial Statements30/09/22 download Created with Sketch. 920.46KB
AC8 Appendix 4G and Corporate Governance Statement30/09/22 download Created with Sketch. 397.2KB
AC8 2022 Annual General Meeting - Key Dates30/09/22 download Created with Sketch. 84.33KB
AC8 Resignation of Chief Executive OfficerPRICE SENSITIVE13/09/22 download Created with Sketch. 86.03KB
AC8 Increase to EuroCann Facility & Sale of Wangara PremisesPRICE SENSITIVE09/09/22 download Created with Sketch. 111.47KB
AC8 Suspension from Official QuotationPRICE SENSITIVE31/08/22 download Created with Sketch. 481.85KB
AC8 Appendix 4EPRICE SENSITIVE31/08/22 download Created with Sketch. 208.86KB
AC8 Appointment of CFO12/08/22 download Created with Sketch. 84.2KB
AC8 June 2022 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE29/07/22 download Created with Sketch. 1.04MB
AC8 March 2022 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE29/04/22 download Created with Sketch. 362.1KB
AC8 AusCann to Expand into European Cannabis MarketPRICE SENSITIVE29/04/22 download Created with Sketch. 218.91KB
AC8 Notification of cessation of securities - AC801/04/22 download Created with Sketch. 22.23KB
AC8 Resignation of Chief Financial Officer11/03/22 download Created with Sketch. 82.79KB
AC8 Appendix 4D and Half-Year Financial Report 31 December 2021PRICE SENSITIVE28/02/22 download Created with Sketch. 759.45KB
AC8 Notification regarding unquoted securities - AC817/02/22 download Created with Sketch. 27.42KB
AC8 AusCann Receives Positive MOC from the U.S. FDA for CPAT-01PRICE SENSITIVE08/02/22 download Created with Sketch. 143.56KB
AC8 December 2021 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE28/01/22 download Created with Sketch. 368.48KB
AC8 AusCann Advances DermaCann Registration & US LaunchPRICE SENSITIVE15/12/21 download Created with Sketch. 554.8KB
AC8 Initial Director's Interest Notice - T. McGrouther15/12/21 download Created with Sketch. 134.09KB
AC8 Final Director's Interest Notice x 215/12/21 download Created with Sketch. 154.35KB
AC8 Appointment of New Chairperson and Director Resignations14/12/21 download Created with Sketch. 107.42KB
AC8 AusCann Completes Successful Meeting with the U.S. FDAPRICE SENSITIVE09/12/21 download Created with Sketch. 171.6KB
AC8 Final Director's Interest Notice x 216/11/21 download Created with Sketch. 186.21KB
AC8 AusCann Board Changes16/11/21 download Created with Sketch. 204.38KB
AC8 Results of Annual General Meeting15/11/21 download Created with Sketch. 165.04KB
AC8 Annual General Meeting - CEO Presentation15/11/21 download Created with Sketch. 7.77MB
AC8 Annual General Meeting - Chairman's Address15/11/21 download Created with Sketch. 154.71KB
AC8 AusCann to Commence Cannabinoid Trial in Spinal Cord InjuryPRICE SENSITIVE12/11/21 download Created with Sketch. 160.14KB
AC8 Change of Director's Interest Notice - K. Bates10/11/21 download Created with Sketch. 177.83KB
AC8 Quarterly Cashflow and Market Update September 2021PRICE SENSITIVE28/10/21 download Created with Sketch. 394.56KB
AC8 AusCann Requests Formal Meeting with the FDA-CVM for CPAT-01PRICE SENSITIVE18/10/21 download Created with Sketch. 147.1KB
AC8 Annual Report14/10/21 download Created with Sketch. 7.27MB
AC8 Letter to Shareholders - Notice of Annual General Meeting14/10/21 download Created with Sketch. 323.33KB
AC8 Notice of Annual General Meeting/Proxy Form14/10/21 download Created with Sketch. 472.72KB
AC8 AusCann Completes US Safety Study for DermaCann RegistrationPRICE SENSITIVE13/10/21 download Created with Sketch. 142KB
AC8 AusCann to Accelerate Human Drug Development Program21/09/21 download Created with Sketch. 122.38KB
AC8 AusCann Appoints US Advisors to Advance CPAT-01 FDA ProgramPRICE SENSITIVE09/09/21 download Created with Sketch. 206.75KB
AC8 Key Company Highlights & Financial Commentary for FY2021PRICE SENSITIVE30/08/21 download Created with Sketch. 129.82KB
AC8 Appendix 4E and Annual Financial StatementsPRICE SENSITIVE30/08/21 download Created with Sketch. 1.01MB
AC8 Appendix 4G and Corporate Governance Statement30/08/21 download Created with Sketch. 407.93KB
AC8 Notification of cessation of securities - AC806/08/21 download Created with Sketch. 21.79KB
AC8 June 2021 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE30/07/21 download Created with Sketch. 1.12MB
AC8 AusCann Commences Australian Product Registration for DogsPRICE SENSITIVE20/07/21 download Created with Sketch. 295.67KB
AC8 AusCann Successful in Tender with Tasmanian Dept of Health01/07/21 download Created with Sketch. 173.26KB
AC8 AusCann Enters into Lease Agreement for R&D FacilityPRICE SENSITIVE17/06/21 download Created with Sketch. 175.01KB
AC8 Change of Director's Interest Notice - G. Starr19/05/21 download Created with Sketch. 170.83KB
AC8 CPAT-01 Improves Pain, Lameness and Quality of Life in DogsPRICE SENSITIVE30/04/21 download Created with Sketch. 313.48KB
AC8 March 2021 Quarterly Activities and Cashflow ReportsPRICE SENSITIVE30/04/21 download Created with Sketch. 315.74KB
AC8 AusCann Receives R&D Tax Incentive Refund of $1.6mPRICE SENSITIVE23/04/21 download Created with Sketch. 85.46KB
AC8 Chief Executive Officer Terms of Appointment23/04/21 download Created with Sketch. 101.62KB
AC8 Change of Director's Interest Notice - M. Johnston19/04/21 download Created with Sketch. 186.86KB
AC8 Initial Director's Interest Notice x 301/04/21 download Created with Sketch. 287.81KB
AC8 Presentation - Cannabis & Hemp Investment Conference23/03/21 download Created with Sketch. 15.08MB
AC8 March 2024 Quarterly Activities and Cashflow Reports
30/04/24PRICE SENSITIVE download Created with Sketch. 148.8KB
AC8 Half Yearly Report and Accounts
03/04/24PRICE SENSITIVE download Created with Sketch. 353.37KB
AC8 Cancel - Proposed issue of securities - AC8
15/02/24 download Created with Sketch. 17.92KB
AC8 Supplementary Prospectus
15/02/24PRICE SENSITIVE download Created with Sketch. 29.43KB
AC8 Withdrawal of Share Purchase Plan
15/02/24 download Created with Sketch. 79.64KB
AC8 Update to Share Purchase Plan Timetable
05/02/24 download Created with Sketch. 108.37KB
AC8 December 2023 Quarterly Activities and Cashflow Reports
30/01/24PRICE SENSITIVE download Created with Sketch. 345.7KB
AC8 Prospectus
25/01/24PRICE SENSITIVE download Created with Sketch. 306.66KB
AC8 Proposed issue of securities - AC8
25/01/24 download Created with Sketch. 28.68KB
AC8 Share Purchase Plan
25/01/24PRICE SENSITIVE download Created with Sketch. 118.66KB
AC8 Additional Secured Loan to ECC
23/01/24PRICE SENSITIVE download Created with Sketch. 139.1KB
AC8 Change of Auditor
03/01/24 download Created with Sketch. 68.5KB
AC8 Change of Company Address
03/01/24 download Created with Sketch. 77.13KB
AC8 Change of Company Secretary
02/01/24 download Created with Sketch. 102.32KB
AC8 Initial Director's Interest Notice - A. Chapman
01/12/23 download Created with Sketch. 159.41KB
AC8 Final Director's Interest Notice - T. McGrouther
01/12/23 download Created with Sketch. 137.57KB
AC8 Appointment of New Chairman
01/12/23 download Created with Sketch. 82.9KB
AC8 Results of Annual General Meeting
30/11/23 download Created with Sketch. 175.1KB
AC8 September 2023 Quarterly Activities and Cashflow Reports
31/10/23PRICE SENSITIVE download Created with Sketch. 1.08MB
AC8 Notice of Annual General Meeting/Proxy Form
27/10/23 download Created with Sketch. 548.54KB
AC8 Letter to Shareholders - Notice of Annual General Meeting
27/10/23 download Created with Sketch. 322.8KB
AC8 Appendix 4G and Corporate Governance Statement
27/10/23 download Created with Sketch. 397.09KB
AC8 Annual Report
27/10/23 download Created with Sketch. 1.36MB
AC8 Notification of cessation of securities - AC8
26/10/23 download Created with Sketch. 23.75KB
AC8 New Secured Loan Agreements Executed with ECC
25/10/23PRICE SENSITIVE download Created with Sketch. 186.47KB
AC8 Change of Address Notifications
15/09/23 download Created with Sketch. 79.69KB
AC8 2023 Annual General Meeting - Key Dates
15/09/23 download Created with Sketch. 81.97KB
AC8 Appendix 4E and 30 June 2023 Preliminary Financial Report
31/08/23PRICE SENSITIVE download Created with Sketch. 495.86KB
AC8 June 2023 Quarterly Activities and Cashflow Reports
31/07/23PRICE SENSITIVE download Created with Sketch. 1.05MB
AC8 Expanded Collaboration with European Cannabis Corp
31/07/23PRICE SENSITIVE download Created with Sketch. 112.93KB
AC8 Final Director's Interest Notice - C. Mews
29/06/23 download Created with Sketch. 141.42KB
AC8 Initial Director's Interest Notice - B. Mitchell
29/06/23 download Created with Sketch. 135.31KB
AC8 Appointment of Independent Non-Executive Director
29/06/23 download Created with Sketch. 84.36KB
AC8 Settlement of Wangara Facility
13/06/23PRICE SENSITIVE download Created with Sketch. 82.92KB
AC8 March 2023 Quarterly Activities and Cashflow Reports
28/04/23PRICE SENSITIVE download Created with Sketch. 1.05MB
AC8 Wangara Facility Sale
04/04/23PRICE SENSITIVE download Created with Sketch. 89.26KB
AC8 AusCann to Partially Divest Animal Health Assets
10/03/23PRICE SENSITIVE download Created with Sketch. 241.08KB
AC8 Appendix 4D and Half-Year Financial Report 31 December 2022
28/02/23PRICE SENSITIVE download Created with Sketch. 477.45KB
AC8 December 2022 Quarterly Activities and Cashflow Reports
31/01/23PRICE SENSITIVE download Created with Sketch. 1.17MB
AC8 Final Director's Interest Notice
03/01/23 download Created with Sketch. 134.69KB
AC8 Resignation of Non-Executive Director
03/01/23 download Created with Sketch. 84.11KB
AC8 Results of Annual General Meeting
30/11/22 download Created with Sketch. 266.86KB
AC8 Market Update for Shareholders
30/11/22PRICE SENSITIVE download Created with Sketch. 819.88KB
AC8 September 2022 Quarterly Activities and Cashflow Reports
31/10/22PRICE SENSITIVE download Created with Sketch. 1.03MB
AC8 Notice of Annual General Meeting/Proxy Form
28/10/22 download Created with Sketch. 398.82KB
AC8 Letter to Shareholders - Notice of Annual General Meeting
28/10/22 download Created with Sketch. 342.19KB
AC8 Annual Report
28/10/22 download Created with Sketch. 870.8KB
AC8 Annual Financial Statements
30/09/22 download Created with Sketch. 920.46KB
AC8 Appendix 4G and Corporate Governance Statement
30/09/22 download Created with Sketch. 397.2KB
AC8 2022 Annual General Meeting - Key Dates
30/09/22 download Created with Sketch. 84.33KB
AC8 Resignation of Chief Executive Officer
13/09/22PRICE SENSITIVE download Created with Sketch. 86.03KB
AC8 Increase to EuroCann Facility & Sale of Wangara Premises
09/09/22PRICE SENSITIVE download Created with Sketch. 111.47KB
AC8 Suspension from Official Quotation
31/08/22PRICE SENSITIVE download Created with Sketch. 481.85KB
AC8 Appendix 4E
31/08/22PRICE SENSITIVE download Created with Sketch. 208.86KB
AC8 Appointment of CFO
12/08/22 download Created with Sketch. 84.2KB
AC8 June 2022 Quarterly Activities and Cashflow Reports
29/07/22PRICE SENSITIVE download Created with Sketch. 1.04MB
AC8 March 2022 Quarterly Activities and Cashflow Reports
29/04/22PRICE SENSITIVE download Created with Sketch. 362.1KB
AC8 AusCann to Expand into European Cannabis Market
29/04/22PRICE SENSITIVE download Created with Sketch. 218.91KB
AC8 Notification of cessation of securities - AC8
01/04/22 download Created with Sketch. 22.23KB
AC8 Resignation of Chief Financial Officer
11/03/22 download Created with Sketch. 82.79KB
AC8 Appendix 4D and Half-Year Financial Report 31 December 2021
28/02/22PRICE SENSITIVE download Created with Sketch. 759.45KB
AC8 Notification regarding unquoted securities - AC8
17/02/22 download Created with Sketch. 27.42KB
AC8 AusCann Receives Positive MOC from the U.S. FDA for CPAT-01
08/02/22PRICE SENSITIVE download Created with Sketch. 143.56KB
AC8 December 2021 Quarterly Activities and Cashflow Reports
28/01/22PRICE SENSITIVE download Created with Sketch. 368.48KB
AC8 AusCann Advances DermaCann Registration & US Launch
15/12/21PRICE SENSITIVE download Created with Sketch. 554.8KB
AC8 Initial Director's Interest Notice - T. McGrouther
15/12/21 download Created with Sketch. 134.09KB
AC8 Final Director's Interest Notice x 2
15/12/21 download Created with Sketch. 154.35KB
AC8 Appointment of New Chairperson and Director Resignations
14/12/21 download Created with Sketch. 107.42KB
AC8 AusCann Completes Successful Meeting with the U.S. FDA
09/12/21PRICE SENSITIVE download Created with Sketch. 171.6KB
AC8 Final Director's Interest Notice x 2
16/11/21 download Created with Sketch. 186.21KB
AC8 AusCann Board Changes
16/11/21 download Created with Sketch. 204.38KB
AC8 Results of Annual General Meeting
15/11/21 download Created with Sketch. 165.04KB
AC8 Annual General Meeting - CEO Presentation
15/11/21 download Created with Sketch. 7.77MB
AC8 Annual General Meeting - Chairman's Address
15/11/21 download Created with Sketch. 154.71KB
AC8 AusCann to Commence Cannabinoid Trial in Spinal Cord Injury
12/11/21PRICE SENSITIVE download Created with Sketch. 160.14KB
AC8 Change of Director's Interest Notice - K. Bates
10/11/21 download Created with Sketch. 177.83KB
AC8 Quarterly Cashflow and Market Update September 2021
28/10/21PRICE SENSITIVE download Created with Sketch. 394.56KB
AC8 AusCann Requests Formal Meeting with the FDA-CVM for CPAT-01
18/10/21PRICE SENSITIVE download Created with Sketch. 147.1KB
AC8 Annual Report
14/10/21 download Created with Sketch. 7.27MB
AC8 Letter to Shareholders - Notice of Annual General Meeting
14/10/21 download Created with Sketch. 323.33KB
AC8 Notice of Annual General Meeting/Proxy Form
14/10/21 download Created with Sketch. 472.72KB
AC8 AusCann Completes US Safety Study for DermaCann Registration
13/10/21PRICE SENSITIVE download Created with Sketch. 142KB
AC8 AusCann to Accelerate Human Drug Development Program
21/09/21 download Created with Sketch. 122.38KB
AC8 AusCann Appoints US Advisors to Advance CPAT-01 FDA Program
09/09/21PRICE SENSITIVE download Created with Sketch. 206.75KB
AC8 Key Company Highlights & Financial Commentary for FY2021
30/08/21PRICE SENSITIVE download Created with Sketch. 129.82KB
AC8 Appendix 4E and Annual Financial Statements
30/08/21PRICE SENSITIVE download Created with Sketch. 1.01MB
AC8 Appendix 4G and Corporate Governance Statement
30/08/21 download Created with Sketch. 407.93KB
AC8 Notification of cessation of securities - AC8
06/08/21 download Created with Sketch. 21.79KB
AC8 June 2021 Quarterly Activities and Cashflow Reports
30/07/21PRICE SENSITIVE download Created with Sketch. 1.12MB
AC8 AusCann Commences Australian Product Registration for Dogs
20/07/21PRICE SENSITIVE download Created with Sketch. 295.67KB
AC8 AusCann Successful in Tender with Tasmanian Dept of Health
01/07/21 download Created with Sketch. 173.26KB
AC8 AusCann Enters into Lease Agreement for R&D Facility
17/06/21PRICE SENSITIVE download Created with Sketch. 175.01KB
AC8 Change of Director's Interest Notice - G. Starr
19/05/21 download Created with Sketch. 170.83KB
AC8 CPAT-01 Improves Pain, Lameness and Quality of Life in Dogs
30/04/21PRICE SENSITIVE download Created with Sketch. 313.48KB
AC8 March 2021 Quarterly Activities and Cashflow Reports
30/04/21PRICE SENSITIVE download Created with Sketch. 315.74KB
AC8 AusCann Receives R&D Tax Incentive Refund of $1.6m
23/04/21PRICE SENSITIVE download Created with Sketch. 85.46KB
AC8 Chief Executive Officer Terms of Appointment
23/04/21 download Created with Sketch. 101.62KB
AC8 Change of Director's Interest Notice - M. Johnston
19/04/21 download Created with Sketch. 186.86KB
AC8 Initial Director's Interest Notice x 3
01/04/21 download Created with Sketch. 287.81KB
AC8 Presentation - Cannabis & Hemp Investment Conference
23/03/21 download Created with Sketch. 15.08MB
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $17.62M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
AC8 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.